Treatment for relapsed or refractory chronic lymphocytic leukaemia: an ongoing challenge

被引：1
|
作者：
Strati, Paolo [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 03期
关键词：
IDELALISIB; FLUDARABINE; RITUXIMAB;
D O I：
10.1016/S2352-3026(17)30020-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E97 / E98
页数：2
相关论文
共 50 条
  • [1] Treatment of relapsed/refractory chronic lymphocytic leukaemia
    Ferrajoli, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 272 - 272
  • [2] Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
    Dretzke, J.
    Barton, P.
    Kaambwa, B.
    Connock, M.
    Uthman, O.
    Bayliss, S.
    Meads, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 19 - 26
  • [3] Another treatment option for relapsed or refractory chronic lymphocytic leukaemia
    Mauro, Francesca R.
    LANCET ONCOLOGY, 2017, 18 (03): : 270 - 271
  • [4] Treatment of relapsed chronic lymphocytic leukaemia
    Stilgenbauer, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S13 - S13
  • [5] Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia
    Yang, Lin
    Banerji, Versha
    LANCET ONCOLOGY, 2024, 25 (04): : 413 - 414
  • [6] The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 110 - 118
  • [7] Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
    Veliz, Marays
    Pinilla-Ibarz, Javier
    CANCER CONTROL, 2012, 19 (01) : 37 - 53
  • [8] Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
    Marchand, Tony
    Pastoret, Cedric
    Damaj, Gandhi
    Lebouvier, Angelique
    Herbaux, Charles
    Moignet, Aline
    Pavlosky, Miguel
    Pavlosky, Astrid
    Blouet, Anaise
    Eloit, Martin
    Launay, Vincent
    Lebreton, Pierre
    Stamatoullas, Aspasia
    Nilsson, Christer
    Ochmann, Marlene
    Prola, Juliette
    Lamy, Thierry
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [9] Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
    Shustik, C.
    Bence-Bruckler, I.
    Delage, R.
    Owen, C. J.
    Toze, C. L.
    Coutre, S.
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1185 - 1196
  • [10] Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
    C. Shustik
    I. Bence-Bruckler
    R. Delage
    C. J. Owen
    C. L. Toze
    S. Coutre
    Annals of Hematology, 2017, 96 : 1185 - 1196
12345